|
RS60926B1
|
|
Ophthalmic composition for the corneal protection
|
|
EP3015110A1
|
|
Biological barrier with cystein for the use in the treatment of naso-pharyngo-tubal infections
|
|
EP3015109A1
|
|
Biological barrier with simethicone for the use in the treatment of naso-pharyngo-tubal infections
|
|
TN2013000017A1
|
|
Use of hmgb1 as' a biological maker of bowel inflammatory conditions, non - invasive method for its detectiion in fecal samples and kit thereof
|
|
CA2791427A1
|
|
Composition comprising streptococcus salivarius useful in the treatment of infections and/or inflammations of the upper respiratory tract
|
|
EP2601525A1
|
|
Use of hmgb1 as a biological marker of bowel inflammatory conditions, non-invasive method for its detection in fecal samples and kit thereof
|
|
KR20130136964A
|
|
Use of hmgb1 as a biological marker of bowel inflammatory conditions, non-invasive method for its detection in fecal samples and kit thereof
|
|
EP2555785A1
|
|
Use of streptococcus salivarius in the treatment of chronic infections of the respiratory tract
|
|
WO2011111084A1
|
|
Pharmaceutical composition based on glycyrrhizin and eg56 polymer for the preparation of anti-inflammatory products
|
|
EP2421520A1
|
|
Albumin and/or mannitol for the treatment of nasal polyposis
|
|
EP2398458A1
|
|
Pharmaceutical composition containing microcolloidal silver and carboxymethyl beta glucan for disinfection of the nasal mucosae
|
|
WO2010016088A1
|
|
Topical intranasal composition usable in the case of nasal obstruction
|
|
EP2229180A1
|
|
Composition comprising superoxide dismutase and carboxv methyl beta-1,3 glucan
|
|
EP1964547A1
|
|
Adhesive topical composition having a barrier action on aphthous ulcers of the oral mucosa
|
|
EP1886669A2
|
|
Phosphoglucan based immunotrophic preparation for the treatment of adenotonsillar hypertrophy
|
|
EP1982694A1
|
|
Anti-oedema composition
|
|
RS51532B
|
|
Otological solution and method for its preparation
|
|
WO2008010241A1
|
|
A liposomal complex of sodium carboxymethyl beta-glucan
|
|
EP1782818A1
|
|
Pharmaceutical composition comprising Bacillus Coagulans and symethicone for the treatment of gastrointestinal pathologies
|
|
EP1468677A2
|
|
An antireflux syrup
|
